Drug Profile
Sodium phenylbutyrate liquid
Alternative Names: NaPB; Sodium phenylbutyrate - Navinta LLC/Tikvah Therapeutics; Sodium phenylbutyrate solution; TIK-201Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Navinta LLC
- Class Antineoplastics; Electrolytes; Phenylbutyrates; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders; Neurodegenerative disorders; Spinal muscular atrophy
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in CNS-disorders in USA (PO, Liquid)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neurodegenerative-disorders in USA (PO, Liquid)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Spinal-muscular-atrophy in USA (PO, Liquid)